Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in China
723 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleTarget-specific immunoPET Imaging of Digestive System Carcinoma
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 400
- Run by
- RenJi Hospital
See details and how to joinNCT06715839 - Phase 2Taking peopleSHR-1701 + Rivoceranib (± SHR-2554) in Advanced GC After First-Line Immunotherapy Failure
- Where
- Shenyang
- Age
- 18 years and over
- People
- 40
- Run by
- Jingdong Zhang
See details and how to joinNCT07311408 - Phase 2Enrolling by invitationNimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy(nCT) in the Treatment of Esophageal Squamous Cell Carcinoma
- Where
- Beijing
- Age
- 18 years to 70 years
- People
- 48
- Run by
- Peking University
See details and how to joinNCT07312578 - Phase 2Taking peopleAdebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy
- Where
- Jinan
- Age
- 18 years to 75 years
- People
- 66
- Run by
- Shandong Tumor Hospital
See details and how to joinNCT07309185 - No phaseTaking peopleImmunoPET Imaging of Pancreatic Cancer
- Where
- Shanghai
- Age
- 18 years to 70 years
- People
- 90
- Run by
- RenJi Hospital
See details and how to joinNCT06602037 - Phase 2Not yet taking people in ChinaA Prospective, Phase II Clinical Study of HIPEC Combined With NIPS and Tislelizumab Conversion Therapy for Gastric Cancer With Peritoneal Metastasis With Positive Cytology Alone or PCI Score ≤10
- Where
- Shijiazhuang
- Age
- 18 years to 75 years
- People
- 30
- Run by
- Hebei Medical University
See details and how to joinNCT07304258 - No phaseTaking peopleClinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors
- Where
- Wuhan
- Age
- 18 years and over
- People
- 56
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07301814 - Phase 3Not yet taking people in ChinaThe Value of Indocyanine Green-guided Near-infrared Fluorescence Technology in Tracing Sentinel Lymph Nodes During Esophagectomy
- Where
- Fuzhou
- Age
- 18 years to 75 years
- People
- 144
- Run by
- Fujian Medical University Union Hospital
See details and how to joinNCT07303231 - No phaseTaking peopleNovel Humanized Ferritin-Based NIR Fluorescent Probe for Identifying Sentinel Lymph Node Metastasis in Early Gastric Cancer
- Where
- Guangzhou
- Age
- 18 years and over
- People
- 47
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT07294638 - Phase 3Taking peopleFeasibility of Enhanced Recovery After Surgery Without Prophylactic Abdominal Drainage Tubes After Laparoscopic Distal Gastrectomy For Gastric Cancer
- Where
- Beijing, Fuzhou, Lanzhou, Xi’an, Zhejiang
- Age
- 18 years to 80 years
- People
- 454
- Run by
- Zuoyi Jiao
See details and how to joinNCT07029269 - Phase 2Taking peopleIparomlimab and Tuvonralimab Combined With Apatinib and Irinotecan Hydrochloride for the Treatment of Advanced Alpha-fetoprotein-producing Gastric Cancer (AFPGC)
- Where
- Shijiazhuang
- Age
- 18 years and over
- People
- 39
- Run by
- Hebei Medical University Fourth Hospital
See details and how to joinNCT07289997 - Phase 2Taking peopleThe Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy as the First-line Treatment for Esophageal Squamous Cell Carcinoma
- Where
- Shijiazhuang
- Age
- 18 years and over
- People
- 25
- Run by
- Hebei Medical University Fourth Hospital
See details and how to joinNCT07290010 - No phaseNot yet taking people in ChinaNovel Humanized Ferritin-based NIR Fluorescent Molecular Probe for Identifying Tumor Margins in Gastric Tissue
- Where
- Guangzhou
- Age
- 18 years and over
- People
- 32
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT07276854 - No phaseTaking peopleOmega-3 Fatty Acids With PD-1 Inhibitors in Advanced Esophageal Cancer
- Where
- Shanghai
- Age
- 18 years and over
- People
- 142
- Run by
- Fudan University
See details and how to joinNCT07272382 - Phase 1/2Taking peopleOncolytic Virus in Esophageal Squamous Cell Carcinoma
- Where
- Chengdu
- Age
- 18 years to 80 years
- People
- 40
- Run by
- Sichuan University
See details and how to joinNCT07061704 - Phase 2Taking peopleClinical Study of Adbelimumab in the Adjuvant Treatment of Esophageal Squamous Cell Carcinoma.
- Where
- Shijiazhuang
- Age
- 18 years and over
- People
- 142
- Run by
- Hebei Medical University Fourth Hospital
See details and how to joinNCT07266480 - Phase 2Taking peopleEfficacy and Safety of Neoadjuvant Envafolimab Combined With Albumin-bound Paclitaxel and Carboplatin for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
- Where
- Shanghai
- Age
- 18 years and over
- People
- 26
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT07266493 - Phase 2Taking peopleA Phase II, Multicenter, Randomized, Controlled Clinical Study Comparing the Efficacy and Safety of Sintilimab Plus SOX Versus SOX Alone as Adjuvant Therapy for PD-L1-Positive, Stage pN3 Gastric Cancer
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 460
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07263386 - Phase 1/2Taking peopleA Trial of the Combination of Afatinib and Palbociclib in Previously Treated Advanced Esophageal Squamous Cell Carcinoma
- Where
- Chengdu
- Age
- 18 years to 75 years
- People
- 45
- Run by
- West China Hospital
See details and how to joinNCT06753747 - Phase 2Taking peopleAdbelimumab Combined With Chemotherapy and Apatinib in Patients With Resectable Esophageal Squamous Cell Carcinoma
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 35
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06576973 - Phase 4Taking peopleSaccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment
- Where
- Xi'an
- Age
- 18 years to 75 years
- People
- 1,248
- Run by
- Yongquan Shi
See details and how to joinNCT07139366 - Phase 2Not yet taking people in ChinaFeasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Adaptive Trial (MRD-ATLAS)
- Where
- Shanghai
- Age
- 18 years to 79 years
- People
- 90
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT07257380 - Phase 1/2Taking peopleHypofractionated Radiotherapy Combined With Immunochemotherapy for Conversion Treatment of Gastroesophageal Junction Adenocarcinoma
- Where
- Chengdu, Xiamen
- Age
- 18 years and over
- People
- 88
- Run by
- West China Hospital
See details and how to joinNCT07072351 - No phaseTaking peopleDistribution Characteristics of Helicobacter Pylori
- Where
- Changchun
- Age
- 18 years to 80 years
- People
- 231
- Run by
- Jilin University
See details and how to joinNCT07253948 - No phaseTaking peopleAI-Assisted Detection and Staging of Gastric Cancer Using Contrast-Enhanced CT
- Where
- Nanjing
- Age
- 18 years to 85 years
- People
- 8,000
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07250347